Diagnostic and Prognostic Values of BMPER in Patients with Urosepsis following Ureteroscopic Lithotripsy.
Bone Morphogenetic Proteins
/ metabolism
C-Reactive Protein
/ metabolism
Carrier Proteins
/ metabolism
Case-Control Studies
Endothelial Progenitor Cells
/ metabolism
Female
Humans
Lithotripsy
/ methods
Logistic Models
Male
Middle Aged
Postoperative Period
Prognosis
Retrospective Studies
Risk Factors
Sepsis
/ metabolism
Ureteroscopy
/ methods
Urinary Tract Infections
/ metabolism
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2019
2019
Historique:
received:
22
07
2018
revised:
09
11
2018
accepted:
10
12
2018
entrez:
26
2
2019
pubmed:
26
2
2019
medline:
14
6
2019
Statut:
epublish
Résumé
The present study aims to investigate the risk factors for urosepsis and the diagnostic and prognostic values of the bone morphogenetic protein endothelial cell precursor-derived regulator (BMPER) in patients with urosepsis following ureteroscopic lithotripsy. A total of 305 patients with unilateral ureteral obstruction caused by calculi were included in the study. Patients were divided into three groups, namely, high, medium, and low perfusion pressure groups. The serum C-reactive protein, procalcitonin, lactate (LAC), and BMPER were measured after operation. A logistic regression model was used to assess the risk factors for postoperative urosepsis. The relationships of BMPER with laboratory parameters were explored with a multiple linear regression model. Receiver operating characteristic (ROC) curves were used to diagnosis urosepsis. The cumulative incidence of the adverse events after operation was calculated and compared by log-rank test. Forty-five patients (14.8%) had an episode of urosepsis after operation. Irrigation pressure was an independent risk factor for urosepsis. LAC and sequential organ failure assessment (SOFA) were associated with BMPER after operation. The area under curve value of BMPER for urosepsis was 0.829 (95% confidence interval [CI], 0.773 to 0.884). Uroseptic patients with higher BMPER concentration exhibited more adverse outcome. BMPER possesses valuable discriminative capacity for urosepsis and is a strong predictor of adverse outcome in patients with urosepsis.
Identifiants
pubmed: 30800678
doi: 10.1155/2019/8078139
pmc: PMC6360565
doi:
Substances chimiques
BMPER protein, human
0
Bone Morphogenetic Proteins
0
Carrier Proteins
0
C-Reactive Protein
9007-41-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8078139Références
Mol Cell Biol. 2003 Aug;23(16):5664-79
pubmed: 12897139
Curr Opin Urol. 2005 Mar;15(2):101-5
pubmed: 15725933
Crit Care. 2007;11(2):R38
pubmed: 17362525
Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):554-60
pubmed: 20042706
Crit Care. 2011;15(2):422
pubmed: 21542896
Blood. 2011 Nov 3;118(18):5040-9
pubmed: 21900199
Int J Antimicrob Agents. 2011 Dec;38 Suppl:51-7
pubmed: 21993485
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2214-22
pubmed: 22772758
Int J Urol. 2013 Oct;20(10):963-70
pubmed: 23714209
Crit Care. 2014 Sep 05;18(5):507
pubmed: 25190134
J Crit Care. 2016 Feb;31(1):68-75
pubmed: 26489483
Clin Chim Acta. 2016 Jan 30;453:205-14
pubmed: 26719034
Shock. 2016 Mar;45(3):259-70
pubmed: 26871664
JAMA. 2016 Feb 23;315(8):775-87
pubmed: 26903336
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Am J Physiol Heart Circ Physiol. 2016 Jul 1;311(1):H24-35
pubmed: 27106039
J Endourol. 2016 Sep;30(9):963-9
pubmed: 27317017
Intensive Care Med. 2016 Dec;42(12):2049-2051
pubmed: 27620298
Curr Opin Urol. 2017 Mar;27(2):133-137
pubmed: 27846034
Inflammation. 2017 Apr;40(2):442-453
pubmed: 27995357
Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1524-1535
pubmed: 28596374
Eur Urol Focus. 2017 Feb;3(1):18-26
pubmed: 28720363
BMC Infect Dis. 2017 Aug 9;17(1):554
pubmed: 28793880
Crit Care Clin. 2018 Jan;34(1):139-152
pubmed: 29149935